Cargando…
Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
In recent years, it has become evident that tumor cells have immune escape mechanisms, and immune checkpoint inhibitor therapy (anti-PD-1/PD-L1 antibody) has shown benefit in various cancers. In endometrial tumors with microsatellite-instability (MSI), somatic mutations have the potential to encode...
Autores principales: | Yamashita, Hitomi, Nakayama, Kentaro, Ishikawa, Masako, Nakamura, Kohei, Ishibashi, Tomoka, Sanuki, Kaori, Ono, Ruriko, Sasamori, Hiroki, Minamoto, Toshiko, Iida, Kouji, Sultana, Razia, Ishikawa, Noriyoshi, Kyo, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814165/ https://www.ncbi.nlm.nih.gov/pubmed/29464025 http://dx.doi.org/10.18632/oncotarget.23790 |
Ejemplares similares
-
Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients
por: Ishikawa, Masako, et al.
Publicado: (2018) -
Genetic analysis and phosphoinositide 3-kinase/protein kinase B signaling pathway status in ovarian endometrioid borderline tumor samples
por: Nakamura, Kohei, et al.
Publicado: (2018) -
KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
por: Nakamura, Kohei, et al.
Publicado: (2016) -
Metastasis of breast cancer to an endometrial polyp, the cervix and a leiomyoma: A case report and review of the literature
por: Razia, Sultana, et al.
Publicado: (2017) -
Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas
por: Ohnishi, Kaori, et al.
Publicado: (2020)